20 hours ago • thepharmaletter.com
Positive new data on Lilly’s Kisunla in Alzheimer’s
20 hours ago • thepharmaletter.com
Positive new data on Lilly’s Kisunla in Alzheimer’s2025-08-04 • techtarget.com
Lilly's Mounjaro rivals Trulicity in cardiovascular risk reduction2025-07-31 • PR Newswire
Lilly's Mounjaro (tirzepatide), a GIP/GLP-1 dual agonist, demonstrated cardiovascular protection in landmark head-to-head trial, reinforcing its benefit in patients with type 2 diabetes and heart disease2025-07-30 • ainvest.com
Eli Lilly Drops 2.86% Despite Positive Trial Results2025-07-30 • PR Newswire
Lilly's Kisunla (donanemab-azbt) showed growing benefit over three years in early symptomatic Alzheimer's disease2025-07-29 • wilmerhale.com
WilmerHale Advises Gate Bioscience on $856M Collaboration and License Agreement with Lilly2025-07-29 • PR Newswire
Lilly's Jaypirca (pirtobrutinib), the first and only approved non-covalent (reversible) BTK inhibitor, met its primary endpoint in a head-to-head Phase 3 trial versus Imbruvica (ibrutinib) in CLL/SLL2025-07-26 • biospace.com
Eli Lilly Commits $856M in Biobucks to Gate Bioscience for New Class of Medicines2025-07-26 • benzinga.com
Eli Lilly's Early Alzheimer's Drug Recommended For Approval By European Drug Regulator's Panel2025-07-26 • EIN Presswire
Havenlly by Lilly Named Presenting Sponsor of Pumpkin Fest 2025 Benefiting Chasin A Dream Foundation2025-07-25 • businesswire.com
INSERTING and REPLACING Gate Bioscience Enters into a Collaboration and License Agreement with Lilly to Discover and Develop Molecular Gate Medicines2025-07-25 • PR Newswire
Lilly completes acquisition of Verve Therapeutics to advance one-time treatments for people with high cardiovascular risk2025-07-25 • PR Newswire
Donanemab receives positive opinion from the Committee for Medicinal Products for Human Use (CHMP) in early symptomatic Alzheimer's disease2025-07-24 • PR Newswire
Lilly confirms date and conference call for second-quarter 2025 financial results announcement2025-07-24 • PR Newswire
Lilly and Verve announce expiration of Verve tender offer2025-07-17 • biospace.com
Health Canada Approves Lilly’s Omvoh® (mirikizumab) for Crohn’s Disease; New Citrate-Free Formulation2025-07-16 • EIN Presswire
'The Many Adventures of Lilly the Skunk' – A Heartwarming Tale of Unlikely Friendship and Wildlife Education2025-07-15 • newswire.ca
Health Canada Approves Lilly's Omvoh® (mirikizumab) for Crohn's Disease; New Citrate-Free Formulation2025-07-11 • barrons.com
Eli Lilly Lead Anti Obesity Drugs Mounjaro Zepbound2025-07-10 • biopharmadive.com
Lilly gets FDA OK of modified dosing for Alzheimer’s drug2025-07-09 • PR Newswire
FDA approves updated label for Lilly's Kisunla (donanemab-azbt) with new dosing in early symptomatic Alzheimer's disease2025-07-09 • newswire.ca
Zepbound™ Kwikpen® (tirzepatide Injection), the First and Only Dual Receptor Agonist for the Treatment of Obesity, Now Approved and Available in Canada19 minutes ago • prnewswire.co.uk
Implantica announces second publication of groundbreaking 5-year results from the landmark RefluxStop® clinical study19 minutes ago • newswire.ca
Meren to Release Second Quarter 2025 Financial Results on Tuesday, August 12, 20252 hours ago • tctmagazine.com
Nikon SLM Solutions and RINA project to drive additive manufacturing applications in hydrogen2 hours ago • automation.com
Mouser Electronics Shares Design Solutions for Advanced Robotics Development in Interactive Ebook from Molex3 hours ago • biomedwire.com
Lantern Pharma (NASDAQ: LTRN) Subsidiary Starlight Therapeutics Cleared by FDA to Begin GBM Combination Trial3 hours ago • techmediawire.com
PowerBank Corporation (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: 103) Installs 4.99 MW Battery Storage System in Ontario3 hours ago • investorwire.com
Alliance Entertainment (NASDAQ: AENT) Elevates Seven Key Leaders to Senior VP Roles3 hours ago • businesswireindia.com
IQM and TOYO Corporation Sign Distribution Agreement to Drive Quantum Adoption in Japan3 hours ago • businesswireindia.com
T&T Group Eyes Raj Nagar Extension with Residential Project Worth Rs. 700 Crore3 hours ago • businesswireindia.com
IDFC FIRST Bank Launches RemitFIRST2India – a New-Age Digital Platform for Seamless and Secure Money Transfers to India3 hours ago • businesswireindia.com
Mafatlal Industries Reports Robust Start to FY26 with Strong Financial Performance in Q1FY263 hours ago • businesswireindia.com
Simplilearn Accelerates AI-Powered Innovation in Digital Skilling with Varun Krishnakumar as Head of Product Management & Design33 minutes ago • EIN Presswire
MindStir Media, Book Publisher in NH, Ranked #12 in New Hampshire on 2025 Inc. 5000 List33 minutes ago • EIN Presswire
MindStir Media Ranks #35 in Media on the 2025 Inc. 5000 List, Cementing Its Status as a National Publishing Powerhouse48 minutes ago • EIN Presswire
Mehr Home Care Expands Home Care Services in Reston, VA and North Virginia to Meet Growing Demand16 hours ago • dailysabah.com
Russia's oil, gas budget revenue falls 27% year-over-year in July16 hours ago • in.investing.com
Oil Prices Rise From Over 1mth Low With Russia Crude Buyer Sanctions In Focus23 hours ago • voice.lapaas.com
Russia to Test AI‑Designed Cancer Vaccine on Humans in Late 20253 hours ago • businesswireindia.com
T&T Group Eyes Raj Nagar Extension with Residential Project Worth Rs. 700 Crore3 hours ago • businesswireindia.com
Mafatlal Industries Reports Robust Start to FY26 with Strong Financial Performance in Q1FY263 hours ago • businesswireindia.com
Royal Stag BoomBox Originals Unveils Its Second Track ‘Sajna Mera’, with a Unique Collaboration of Melody and Hip Hop Between Neeti Mohan, Panther and Ravator13 hours ago • EIN Presswire
Aerospace Robotics Market 2025-2029: Unveiling Growth Developments with the Latest Updates13 hours ago • blackmorevale.net
The New Blackmore Vale Magazine13 hours ago • bbc.co.uk
Plans for large solar farm near former collieryStay ahead with real-time headlines from top sources, categorized by sector and country.